Sightnode Medi And Pharmaceutical India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 84.72%
- Profit Growth 53.08%
- Ebitda 47.42%
- Net Worth 2.70%
- Total Assets 25.44%
About Sightnode Medi And Pharmaceutical India
Sightnode Medi And Pharmaceutical India Private Limited (SMAPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 May 2018 (Six years and nine months 1 days old ). Its registered office is in Panchkula, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ajeet Kumar and Nishee Kumari serve as directors at the Company.
Company Details
-
Location
Panchkula, Haryana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909HR2018PTC074058
-
Company No.
074058
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 May 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Sightnode Medi And Pharmaceutical India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajeet Kumar
|
Director | 14-May-2018 | Current |
|
Nishee Kumari
|
Director | 14-May-2018 | Current |
Financial Performance of Sightnode Medi And Pharmaceutical India.
Sightnode Medi And Pharmaceutical India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 84.72% increase. The company also saw a substantial improvement in profitability, with a 53.08% increase in profit. The company's net worth moved up by a moderate rise of 2.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sightnode Medi And Pharmaceutical India?
Unlock access to Sightnode Medi And Pharmaceutical India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sightnode Medi And Pharmaceutical India?
Sightnode Medi And Pharmaceutical India has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sightnode Medi And Pharmaceutical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sightnode Medi And Pharmaceutical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.